The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
WCLC 2022 | Mitigating the effects of COVID – how does lung cancer recover?
David Baldwin, MD, FRCP, Nottingham University Hospitals NHS Trust, Nottingham, UK, discusses the impact of covid on lung cancer and how the effects can be mitigated. During the COVID-19 pandemic, early diagnosis was delayed. The necessary precautions during the pandemic were to stay at home, particularly when experiencing a cough. As a result, there was a 30% reduction in people diagnosed with lung cancer, leading to a reduction in survival. Efforts our now in progress to increase screening and awareness in regard to early presentation and diagnosis to mitigate the effect of COVID-19 on lung cancer. This interview took place at the IASLC 2022 World Conference on Lung Cancer congress in Vienna, Austria.
